We’ve put together a short list of our favourite essays and longform stories. These stories don't always make the headlines ...

What’s driving anti-immigrant healthcare blockades? Sharon Ekambaram from Lawyers for Human Rights says it's everything from ...

We tell a good story with the science to back it. Support great journalism today.

Obesity is surging in South Africa. What’s fuelling this epidemic and how does it contribute to diabetes and heart disease, SA’s top killers?

The United States government has appointed the first African head of its Aids fund, Pepfar. John Nkengasong, a Cameroonian virologist with US citizenship, will need to establish the potential impact ...

Twenty-five years ago, South Africans battled for ARVs to keep people alive. Now the focus has shifted to medicines that can prevent HIV altogether. Health Beat looks at Aids at 44 — and how the story ...

The South African government says it could fill the potential gap in the number of doses it will need of the twice-yearly HIV ...

We tell a good story with the science to back it. Support great journalism today.

Gilead Sciences, the maker of a twice-a year anti-HIV injection, has approached South Africa’s medicine regulator to discuss how to get the shot registered locally as fast as possible in the country.